2Madsen K, Schenholm M, Jahnke G, et al. Hyaluronate binding to intact comessas and cultured endothelial cell [J].Ivest Ophthal Visual Sci, 1989, 30:2132- 2137.
3Pape LG, Balazs EA. The use of sodium hyaluronate in human anterior segment surgery[J]. Ophthalmology, 1980,87:699.
4Algvere P. Intravitreal implantation of a high-molecular hyaluronic acid in surgery for retinal detachment[J]. Acta Ophthalmol, 1971, 49:975
5Bertchez SF, Camber O, Tabatabay C, et al. Use ofhyaluronic acid in ocular therapy[A]. In: Edman P ed.Biopharmaceutics of Ocular Drug Delivery[M].Boca Raton: CRC, 1993:105-120.
6Balazs EA, Denlinger JL. Viscosupple mentation: A new concept in the treatment of osteoarthritis[J]. J Rheumatol,1993, 39 (Suppl): 3-9.
7Forrester JV, Balazs EA. Inhibition of phagocytosis by high molecular weight hyaluronate[J]. Immunology, 1980,40:435- 446.
8Ghosh P. Hyaluronan and biochemical lesions of osteoarthritis[J]. Immuno Cell Biol, 1996, 74: A9-A12.
9Dahl LB, Dahl IM, Engstrom-Laurent A,Granath K. concentration and molecular weight of sodium hyaluronate in synovial fluids from patients with rheumatoid arthritis and other arthropathies[J]. Ann Rheum Dis, 1985, 44:817-822.
10Peyron JG, Intra articular hyaluronan in the treatment of osteoarthritis state-of-the-art review[J]. Rheumatol, 1993,39 (Suppl): 10-15.
